Canada vs Guatemala: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Canada
85.0%
in 2025
Guatemala
85.0%
in 2025
Canada rank
96th
Guatemala rank
96th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Canada
- Guatemala
How they compare
Canada currently reports 85.0% against 85.0% in Guatemala, a difference of 0.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Canada ahead.
Canada ranks 96th and Guatemala ranks 96th of 194 countries.
Across the 3 decades both report, Canada averaged higher in 2 and Guatemala in 1.
Head to head by decade
| Decade | Canada | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 0.0% | 46.0% | Canada |
| 2010s | 76.1% | 57.9% | 18.2% | Canada |
| 2020s | 84.7% | 87.7% | 3.0% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Canada or Guatemala?
- Canada, at 85.0% against 85.0% in Guatemala as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Canada and Guatemala?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Guatemala?
- 18 years are reported by both, from 2008 to 2025.
- How do Canada and Guatemala rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Canada ranks 96th and Guatemala ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.